145 related articles for article (PubMed ID: 31237120)
1. Transcatheter closure of atrial septal communication: Impact on quality of life in mid-term follow-up.
Lelakowska M; Matusik PT; Podolec PS; Olszowska M; Nessler JM; Podolec N; Przewłocki T; Komar M
Adv Clin Exp Med; 2019 Aug; 28(8):1079-1085. PubMed ID: 31237120
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter closure of atrial septal communication: impact on P-wave dispersion, duration, and arrhythmia in mid-term follow-up.
Lelakowska M; Komar M; Matusik PT; Nessler J; Podolec P; Olszowska M
Kardiol Pol; 2018; 76(10):1465-1473. PubMed ID: 30067278
[TBL] [Abstract][Full Text] [Related]
3. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
4. Atrial septal defect and patent foramen ovale: early and long-term effects on endothelial function after percutaneous occlusion procedure.
Scicchitano P; Gesualdo M; Cortese F; Acquaviva T; de Cillis E; Bortone AS; Ciccone MM
Heart Vessels; 2019 Sep; 34(9):1499-1508. PubMed ID: 30895384
[TBL] [Abstract][Full Text] [Related]
5. Malattached septum primum and deficient septal rim predict unsuccessful transcatheter closure of atrial communications.
Ostermayer SH; Srivastava S; Doucette JT; Ko HH; Geiger M; Parness IA; Love BA
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1195-203. PubMed ID: 26332722
[TBL] [Abstract][Full Text] [Related]
6. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.
Singh V; Badheka AO; Patel NJ; Chothani A; Mehta K; Arora S; Patel N; Deshmukh A; Shah N; Savani GT; Rathod A; Manvar S; Thakkar B; Panchal V; Patel J; Palacios IF; Rihal CS; Cohen MG; O'Neill W; De Marchena E
Catheter Cardiovasc Interv; 2015 May; 85(6):1073-81. PubMed ID: 25534392
[TBL] [Abstract][Full Text] [Related]
7. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
[TBL] [Abstract][Full Text] [Related]
8. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter device occlusion of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance.
Salomé N; Braga P; Gonçalves M; Rodrigues A; Ribeiro J; Fonesca C; Pinto F; Ribeiro VG
Rev Port Cardiol; 2004 May; 23(5):709-17. PubMed ID: 15279455
[TBL] [Abstract][Full Text] [Related]
11. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale.
Earing MG; Cabalka AK; Seward JB; Bruce CJ; Reeder GS; Hagler DJ
Mayo Clin Proc; 2004 Jan; 79(1):24-34. PubMed ID: 14708945
[TBL] [Abstract][Full Text] [Related]
12. Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale.
Schoen SP; Boscheri A; Lange SA; Braun MU; Fuhrmann J; Kappert U; Strasser RH
Heart; 2008 Jul; 94(7):844-7. PubMed ID: 18070946
[TBL] [Abstract][Full Text] [Related]
13. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
[TBL] [Abstract][Full Text] [Related]
14. Intracardiac echocardiography during atrial septal defect and patent foramen ovale device closure in pediatric and adolescent patients.
Medford BA; Taggart NW; Cabalka AK; Cetta F; Reeder GS; Hagler DJ; Johnson JN
J Am Soc Echocardiogr; 2014 Sep; 27(9):984-90. PubMed ID: 24998516
[TBL] [Abstract][Full Text] [Related]
15. Early-mid term follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience.
Aytemir K; Oto A; Ozkutlu S; Kaya EB; Canpolat U; Yorgun H; Sahiner L; Kabakçi G
J Interv Cardiol; 2012 Aug; 25(4):375-81. PubMed ID: 22612236
[TBL] [Abstract][Full Text] [Related]
16. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation.
Loar RW; Johnson JN; Cabalka AK; Cetta F; Hagler DJ; Eidem BW; Taggart NW
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1234-7. PubMed ID: 23239614
[TBL] [Abstract][Full Text] [Related]
17. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous closure of patent foramen ovale and atrial septal defect: procedure outcome and medium-term follow-up.
Egred M; Andron M; Albouaini K; Alahmar A; Grainger R; Morrison WL
J Interv Cardiol; 2007 Oct; 20(5):395-401. PubMed ID: 17880337
[TBL] [Abstract][Full Text] [Related]
19. [Transcatheter closure of atrial septal defects in adults. Practicality and safety of four different closure systems used in 102 patients].
La Rosée K; Krause D; Becker M; Beuckelmann DJ; Deutsch HJ; Höpp HW
Dtsch Med Wochenschr; 2001 Sep; 126(38):1030-6. PubMed ID: 11565056
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
Van Den Branden BJ; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
J Interv Cardiol; 2011 Jun; 24(3):264-70. PubMed ID: 21198853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
